Search research articles
Contact Us
Filters
Showing results (1-10 of 118) with videos related to
Page
of 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 24, 2018
PARPi related toxicities: do we need more appropriate instruments to evaluate it?
D Lorusso, S Pignata
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2000
Single agents should be administered in preference to combination chemotherapy for the treatment of patients over 70 years of age with advanced ovarian carcinoma
S Pignata, S Monfardini
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Role of adjuvant chemotherapy in early-stage endometrioid and clear-cell ovarian cancer
D Lorusso, S Pignata
Critical Reviews in Oncology/Hematology
|
May 12, 2012
Angiogenesis: a promising therapeutic target for ovarian cancer
A Bamias, S Pignata, E Pujade-Lauraine
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2019
Chemotherapy-free treatments: are we ready for prime time?
D Lorusso, S Pignata, A Gonzalez-Martin
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 12, 2018
Latest clinical evidence and further development of PARP inhibitors in ovarian cancer
M R Mirza, S Pignata, J A Ledermann
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2002
Quality of life: gynaecological cancers
S Pignata, E Ballatori, G Favalli, et al.
Digestion
|
January 1, 1988
Postheparin plasma diamine oxidase in subjects with small bowel disease. Diagnostic efficiency of a simplified test
L D'Agostino, B Daniele, S Pignata, et al.
Biochemical Pharmacology
|
January 1, 1989
Modifications in enterocyte diamine oxidase distribution induced by heparin in the rat
L D'Agostino, B Daniele, S Pignata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2018
Adjuvant treatment of high-risk renal cell carcinoma: the jury is still out
G Procopio, P Sepe, E Verzoni, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 118) with videos related to
Sort By:
Page
of 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 24, 2018
PARPi related toxicities: do we need more appropriate instruments to evaluate it?
D Lorusso, S Pignata
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2000
Single agents should be administered in preference to combination chemotherapy for the treatment of patients over 70 years of age with advanced ovarian carcinoma
S Pignata, S Monfardini
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Role of adjuvant chemotherapy in early-stage endometrioid and clear-cell ovarian cancer
D Lorusso, S Pignata
Critical Reviews in Oncology/Hematology
|
May 12, 2012
Angiogenesis: a promising therapeutic target for ovarian cancer
A Bamias, S Pignata, E Pujade-Lauraine
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2019
Chemotherapy-free treatments: are we ready for prime time?
D Lorusso, S Pignata, A Gonzalez-Martin
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 12, 2018
Latest clinical evidence and further development of PARP inhibitors in ovarian cancer
M R Mirza, S Pignata, J A Ledermann
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2002
Quality of life: gynaecological cancers
S Pignata, E Ballatori, G Favalli, et al.
Digestion
|
January 1, 1988
Postheparin plasma diamine oxidase in subjects with small bowel disease. Diagnostic efficiency of a simplified test
L D'Agostino, B Daniele, S Pignata, et al.
Biochemical Pharmacology
|
January 1, 1989
Modifications in enterocyte diamine oxidase distribution induced by heparin in the rat
L D'Agostino, B Daniele, S Pignata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2018
Adjuvant treatment of high-risk renal cell carcinoma: the jury is still out
G Procopio, P Sepe, E Verzoni, et al.
Page
of 12